South East Asian countries, especially Vietnam, Thailand, Indonesia, and Malaysia present good opportunities for krill oil consumption growth in the next three to five years, says krill oil supplier Aker BioMarine.
Twelve weeks of daily supplementation of a dietary supplement containing krill oil, astaxanthin, and lower molecular weight hyaluronic acid has been found to reduce joint pain and improve joint function among individuals with mild osteoarthritis.
Here is the round-up of the latest nutraceutical trends in Asia-Pacific, including how opportunities in India's nutraceutical sector are seen as 'far bigger' than the pharmaceutical sector, the growing krill oil supplement market in China,...
More Chinese consumers have been taking krill oil supplementation in the past two to three years, with anti-ageing as one of the most common reasons, says CEO of krill oil supplier firm Aker BioMarine.
Florida-based ingredient firm Valensa International is expanding into South Korea’s joint health supplement market where it sees an opportunity for novel ingredients beyond glucosamine and chondroitin.
Swisse will be applying for new therapeutic claims related to knee health under the nascent ‘assessed listed’ medicines scheme in Australia for its krill oil supplement, following positive human clinical trial findings.
This round-up will feature the booming probiotics sector in South Korea, krill oil’s common uses in Japan, the findings of a new human clinical trial involving nicotinamide mononucleotide (NMN) and Taiwan’s efforts in banning unnecessary animal tests.
In this round-up we look at the latest South Korea’s nutraceutical industry developments, including Korea Ginseng Corp taking the top spot for the country’s health functional foods sales chart, and the re-evaluation of co-enzyme Q10 and squalene’s uses...
Krill oil dietary supplements are proving increasingly popular among middle-aged consumers in China, according to the biggest brand in terms of sales on Tmall during the recent Double 11 shopping festival.
South Korea is tightening its watch over the quality of krill oil by proposing to follow the CODEX standards, including setting a minimum requirement for phospholipids concentration and limiting the amount of linoleic acid and myristic acid.
This round-up of developments in South Korea's nutraceutical industry features MFDS' increased inspection of imported krill oil products, Amorepacific growing its global green tea probiotics business, and a look into beauty-from-within trends...
South Korea’s Ministry of Food and Drug Safety (MFDS) will continue with its high profile crackdown on non-compliant probiotic and krill oil products, with a market expert telling us it is ‘no coincidence’ that these categories remain in the spotlight.
The South Korean authorities has introduced a one-year long policy which requires all imported Antarctic krill products, including supplements, to be proven safe before they can be successfully imported into the country.
South Korea’s authorities have recalled 12 krill oil products after safety tests found banned substances or excessive use of solvents in the products, leading to the authorities calling for tougher inspections at customs.
Norway’s NY-O3 has introduced pure krill oil supplements to the China market, and believes it is the first such product in the country to have been authenticated by an independent third-party testing lab.
Aker BioMarine has entered into a partnership with the Lupus Research Alliance that will potentially help sufferers of the disorder, as well as help Aker better understand the mechanisms of action of krill oil.
In a relentless pursuit of 'scale', Aker BioMarine has now become the world's undisputed leader in krill oil supply. The purpose is not mere aggrandizement, but rather, to have the necessary wherewithal to grow the category with science...